The Genetics Company


The Genetics Company has developed and is selling an Alzheimer antibody based diagnostic tool kit for research and clinical purposes. In addition, it is exploiting expertise and preclinical assets achieved in the the WNT-pathway relating to cancer.

The Genetics Company has developed and is selling an Alzheimer antibody based diagnostic tool kit for research and clinical purposes. In addition, it is exploiting expertise and preclinical assets achieved in the the WNT-pathway relating to cancer.

Company (Alive / Active)

Phone:

Fax:




Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
The Genetics Company $0M Nov 30, 2018
See all 11 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related The Genetics Company Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Novartis Venture FundsCorporate VentureBasel, SwitzerlandOther Investors
See all 1 investors

Competitors

Company Status Description Investors
See all 11 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cutoff point delta ct. method for her2 pcr testing in breast cancer Feb 13, 2013 Aug 16, 2016 Patent
P-selectin ligand protein Jul 03, 2008 Jul 31, 2012 Patent
Human gil-19/ae289 proteins Dec 01, 2008 Nov 01, 2011 Patent
Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases May 14, 2009 Sep 06, 2011 Patent
Mu-1, member of the cytokine receptor family Jan 28, 2010 Aug 09, 2011 Patent
See all 32 patents